FDA approves antibody to protect infants from RSV
By Brenda Goodman, CNN (CNN) — This fall, parents and pediatricians will have a new option to protect babies from a lung-attacking virus that is the leading cause of hospitalization in infants under a year old in the United States every year. The US Food and Drug Administration approved nirsevimab to protect newborns from respiratory
Continue Reading